Under David’s leadership, Slade has grown to become a leading national pharmacy service provider for public and private hospitals.
David has a passion for hospital pharmacy, compounding and the application of information technology to make life easier for pharmacists – and produce better patient outcomes. His deep understanding of the healthcare industry not only underpins the 50-year-old Slade Pharmacy business, but has been integral to the evolution of Slade Health. Seeing an opportunity to evolve outside of pharmacy, David established Slade Health in 2012. He recently led the acquisitions of Fresenius Kabi, McBeath Oncology Compounding and mobiLife, making Slade Health one of Australia’s largest chemotherapy compounders.
David is passionate about innovation and using technology to improve business operations. He was the first in Australia to introduce robotic dispensing technology into hospital pharmacy and to develop and deploy an online ordering system for chemotherapy and unique barcoding technology to support patient safety in hospitals.
David is also a Director and Board member of Icon Group.